100 related articles for article (PubMed ID: 1344218)
41. Patients With Invasive Ductal Carcinoma Have Reduced Levels of Decorin Expression in Their Breast Tissue Compared to Patients With Fibroadenoma While Plasma Decorin Remains Unchanged.
Falakian Z; Shahani T; Rezaie R; Mazloomzadeh S; Sirati F; Jalilvand A; Jahangiri F; Bahmani P; Jadali F; Atarian S; Eghdam-Zamir R; Biglari A
Arch Iran Med; 2018 Nov; 21(11):509-517. PubMed ID: 30551691
[TBL] [Abstract][Full Text] [Related]
42. The loss of lectin reactivity from human endometrium is a feature of malignant change.
Sivridis E; Agnantis N
Pathol Res Pract; 1996 Oct; 192(10):989-97. PubMed ID: 8958548
[TBL] [Abstract][Full Text] [Related]
43. [Expression of galectin-3 and Sambucus nigra agglutinin and its clinicopathological significance in benign and malignant lesions of breast].
Chen G; Zou Q; Yang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):584-9. PubMed ID: 20622331
[TBL] [Abstract][Full Text] [Related]
44. Lectin-binding patterns of breast carcinoma: significance on structural atypism.
Ohuchi N; Nose M; Abe R; Kyogoku M
Tohoku J Exp Med; 1984 Aug; 143(4):491-9. PubMed ID: 6548589
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical profile of the estrogen and progesterone receptors in mammary benign lesions.
Moise M; Răducan S; Boscu A; Jianu A; Niculescu M; Selaru M; Motoc A
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):875-82. PubMed ID: 23272545
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical studies on expression of human vascular smooth muscle myosin heavy chain isoforms in normal mammary glands, benign mammary disorders and mammary carcinomas.
Ohyabu I; Takasaki T; Akiba S; Nomura S; Enokizono N; Sagara Y; Hiroi J; Nagai R; Yoshida H
Pathol Int; 1998 Jun; 48(6):433-9. PubMed ID: 9702855
[TBL] [Abstract][Full Text] [Related]
47. A comparison of the pattern of cathepsin-D expression in fibroadenoma, fibrocystic disease, preinvasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 1999 Aug; 31(3):247-51. PubMed ID: 10503271
[TBL] [Abstract][Full Text] [Related]
48. The extent of apoptosis is inversely associated with bcl-2 expression in premalignant and malignant breast lesions.
Mustonen M; Raunio H; Pääkkö P; Soini Y
Histopathology; 1997 Oct; 31(4):347-54. PubMed ID: 9363451
[TBL] [Abstract][Full Text] [Related]
49. Expression of cyclooxygenase-2 in fine-needle aspirates from breast carcinoma and benign breast diseases.
Sucić M; Boban D; Marković-Glamocak M; Jakić-Razumović J; Vrbanec D; Ries S; Gjadrov-Kuvezdić K; Cobanov AM; Podolski P; Martinović I; Erak V; Budisić Z; Ivrlac R; Unusić J
Breast; 2003 Feb; 12(1):51-7. PubMed ID: 14659355
[TBL] [Abstract][Full Text] [Related]
50. The lectin-binding sites for peanut agglutinin in invasive breast ductal carcinomas and their role as a prognostic factor.
Mustac E; Melato M; Sasso F; Valkovic T; Bottin C; Jonjic N
J Cancer Res Clin Oncol; 1996; 122(11):693-7. PubMed ID: 8898981
[TBL] [Abstract][Full Text] [Related]
51. Versatility of biotin-labeled lectins and avidin-biotin-peroxidase complex for localization of carbohydrate in tissue sections.
Hsu SM; Raine L
J Histochem Cytochem; 1982 Feb; 30(2):157-61. PubMed ID: 7037937
[TBL] [Abstract][Full Text] [Related]
52. Lectin binding to serous ovarian tumours.
Söderström KO
J Clin Pathol; 1988 Mar; 41(3):308-13. PubMed ID: 2452177
[TBL] [Abstract][Full Text] [Related]
53. Expression of Tn antigen and N-acetyllactosamine residues in malignant and benign human breast tumors detected by lectins and monoclonal antibody 83D4.
Konska G; Guillot J; De Latour M; Fonck Y
Int J Oncol; 1998 Feb; 12(2):361-7. PubMed ID: 9458363
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical demonstration of histone H1(0) in human breast carcinoma.
Kostova NN; Srebreva LN; Milev AD; Bogdanova OG; Rundquist I; Lindner HH; Markov DV
Histochem Cell Biol; 2005 Nov; 124(5):435-43. PubMed ID: 16158288
[TBL] [Abstract][Full Text] [Related]
55. PLASMINOGEN AND ANGIOSTATIN LEVELS IN FEMALE BENIGN BREAST LESIONS.
Tykhomyrov AA; Vovchuk IL; Grinenko TV
Ukr Biochem J; 2015; 87(5):103-12. PubMed ID: 26717601
[TBL] [Abstract][Full Text] [Related]
56. Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma.
Arihiro K; Kaneko M; Fujii S; Inai K; Yokosaki Y
Breast Cancer; 2000 Jan; 7(1):19-26. PubMed ID: 11029766
[TBL] [Abstract][Full Text] [Related]
57. Trace element content in breasts with fibrocystic disease.
Kanias GD; Kouri E; Arvaniti H; Karaiosifidi H; Kouneli S
Biol Trace Elem Res; 1994; 43-45():363-70. PubMed ID: 7710850
[TBL] [Abstract][Full Text] [Related]
58. Peanut lectin binding in breast carcinoma. Lack of correlation with estrogen receptor content.
Stanley MW; Kiang DT; Sibley RK
Cancer; 1986 Nov; 58(9):2046-51. PubMed ID: 2428465
[TBL] [Abstract][Full Text] [Related]
59. MUC-1-/ESA+ progenitor cells in normal, benign and malignant human breast epithelial cells.
Lü X; Li H; Xu K; Nesland JM; Suo Z
Histol Histopathol; 2009 Nov; 24(11):1381-90. PubMed ID: 19760587
[TBL] [Abstract][Full Text] [Related]
60. Behaviour of estrogen receptor, histological correlation, and clinical outcome in patients with benign breast disorders.
Khanna AK; Tapodar JK; Khanna HD; Khanna S; Khanna A
Eur J Surg; 2002; 168(11):631-4. PubMed ID: 12699101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
